Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-23

FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ambien (zolpidem tartrate) submitted by Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambien (zolpidem)

Snippet

SUPPL AP for AMBIEN (ZOLPIDEM TARTRATE)